Crypto stands on the cusp of a major bull run, and the possibility of Bitcoin hitting $100,000 feels more real by the day.
When it comes to the second in command, Ethereum seems ready to join the party.
After months of carving out a short-term reversal base, ETH is flirting with a critical polarity level of around $2,850.
If and when we get a decisive breakout about this area, then the path of least resistance will be higher, with a clear shot toward its year-to-date highs near $4,000.
That would ultimately confirm Bitcoin's breakout,...
Today is Election Day in the U.S., and while the spotlight is on the political arena, this is the perfect time to ignore the noise and focus on what really matters.
When it comes to seasonality, some of the best signals that we get are when the market does not follow the historical pattern or seasonal trend.
The chart below shows the S&P 500's average monthly returns during election years.
As you can see, we’re leaving the September and October window, which are the two worst months, and entering...
One group of stocks I am watching closely right now is biotechs.
Despite the industry's lackluster performance over the previous three months, I think biotechs are brewing up something big.
Here’s the equally-weighted SPDR Biotech ETF $XBI.
XBI has been consolidating in a narrow range, and holding just above the breakout level from a multi-year base.
Given all the price memory around this area, it’s an ideal spot for buyers to step in and spark a rebound rally.
If it happens, we'll be looking for XBI to break out of this triangle pattern, which would confirm a reversal of the primary trend. This would also position the entire biotech space to attract some bullish rotation.
Maybe its getting underway now. Biotechs were on fire today with XBI closing higher by 2.30%.
Strazza likes the setup here a lot as well. He just got long calls in the...
Consumer Discretionary stocks are a reliable gauge of risk appetite and market health.
Consider these as automobiles, retail, and homebuilding—industries that offer products and services consumers purchase with their discretionary income.
When investors favor these stocks, it indicates a higher level of risk-seeking behavior.
One simple way to assess them is by comparing their performance to the broader market.
The chart below illustrates Large Cap Consumer Discretionary Sector relative to the S&P 500, potentially forming a major 10-year top.
Notice how this ratio has been holding near its lower bounds for quite some time.
If you believe the bull market still has legs, the expectation would be for discretionary stocks to start outperforming.
On the other hand, if you bet this top completes, you expect risk assets to come under pressure.
Typically, a strong dollar would suggest a defensive tone for risk assets. But not this time.
Despite the dollar's impressive run, equities are holding their ground and showing serious resilience. Just last week, the S&P 500 closed at all-time highs.
And when you dig into the chart, DXY is still stuck in the middle of a range
When I think about the strongest stocks, I’m not just looking for outperformance across different timeframes. The strongest stocks should be back to our through their old bull market highs.
Let’s discuss the materials sector in this light.
The bubble chart below shows the change from the 2021-2022 highs on the Y axis and the 3-month relative change on the X axis. I'm graphing all the materials industry groups to see how they stack up.
The areas that really catch my attention are those enclosed in the oval at the top of the chart, as they show the groups returning to their previous highs and potentially breaking out of multi-year bases.
What sets uranium apart, however, is its position on the far right of the chart. This speaks to the strong outperformance from these stocks over the trailing quarter.
The uranium theme becomes increasingly compelling when we look at the price chart…
Check out this decade-long base for the Uranium ETF $URA: